Nymox Pharmaceutical
NYMX
#10757
Rank
NZ$33.21 M
Marketcap
Country
NZ$0.36
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): NZ-$0.09947

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$0.11. In 2022 the company made an earnings per share (EPS) of NZ-$0.15 an increase over its 2021 EPS that were of NZ-$0.27.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.09947-31.68%
2022NZ-$0.15-46.67%
2021NZ-$0.27-11.76%
2020NZ-$0.31-15%
2019NZ-$0.365.26%
2018NZ-$0.35-26.92%
2017NZ-$0.47-7.14%
2016NZ-$0.51-40.43%
2015NZ-$0.86291.67%
2014NZ-$0.22-7.69%
2013NZ-$0.24-43.48%
2012NZ-$0.42-25.81%
2011NZ-$0.5655%
2010NZ-$0.3625%
2009NZ-$0.290.08%
2008NZ-$0.29-11.12%
2007NZ-$0.33-0.16%
2006NZ-$0.3328.59%
2005NZ-$0.25-12.49%
2004NZ-$0.29-16.05%
2003NZ-$0.3519.07%
2002NZ-$0.2914.45%
2001NZ-$0.25-22.16%
2000NZ-$0.335.64%
1999NZ-$0.31-34.59%
1998NZ-$0.47-3.6%
1997NZ-$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-11,233.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-1,283.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.92-4,606.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.22-51,584.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.53-17,066.67%๐Ÿ‡บ๐Ÿ‡ธ USA